CYTALUX
Peakpafolacianine injection
NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Nov 2021
Lifecycle
Peak
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action Pafolacianine binds to alpha and beta folate receptors (FR) on cells, is internalized via receptor-mediated endocytosis, and accumulates intracellularly. Pafolacianine enhances lesion visualization through the differential level of expression and accessibility of folate…
Indications (1)
Loss of Exclusivity
LOE Date
Oct 4, 2033
92 months away
Patent Expiry
Oct 4, 2033
Exclusivity Expiry
Nov 29, 2028